| For: | Halle-Smith JM, Powell-Brett S, Roberts K, Chatzizacharias NA. Resection of isolated liver oligometastatic disease in pancreatic ductal adenocarcinoma: Is there a survival benefit? A systematic review. World J Gastrointest Surg 2023; 15(7): 1512-1521 [PMID: 37555114 DOI: 10.4240/wjgs.v15.i7.1512] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i7/1512.htm |
| Number | Citing Articles |
| 1 |
Marianna Maspero, Francesca Albanesi, Carlo Sposito, Vincenzo Mazzaferro, Andrea Schlegel. Cancer Metastasis, Management and Complications: An Interdisciplinary Approach. Interdisciplinary Cancer Research 2024; 20: 93 doi: 10.1007/16833_2024_315
|
| 2 |
Noah Clements, Jeremy Gaskins, Robert C. G. Martin. Surgical Outcomes in Stage IV Pancreatic Cancer with Liver Metastasis Current Evidence and Future Directions: A Systematic Review and Meta-Analysis of Surgical Resection. Cancers 2025; 17(4): 688 doi: 10.3390/cancers17040688
|
| 3 |
Toshiro Masuda, Hirohisa Okabe, Takeshi Morinaga, Naoki Umezaki, Hidetoshi Nitta, Masahiko Hirota, Ryoichi Kurano, Toru Beppu, Hiroki Sugita. An 8-Year Survivor after Three-Time Hepatectomies for Metachronous Pancreatic Adenocarcinoma Liver Metastases. Surgical Case Reports 2026; 12(1): n/a doi: 10.70352/scrj.cr.25-0242
|
| 4 |
Antonios-Apostolos Tentes, Dimitrios Kyziridis, Apostolos Kalakonas, Alexandros Iliadis, Anastasia Fotiadou. Pancreatic cancer with synchronous peritoneal and hepatic metastases: A case report. International Journal of Surgery Case Reports 2024; 118: 109588 doi: 10.1016/j.ijscr.2024.109588
|
| 5 |
D. Brock Hewitt, Christopher L. Wolfgang. The Role of Surgery in “Oligometastatic” Pancreas Cancer. Surgical Clinics of North America 2024; 104(5): 1065 doi: 10.1016/j.suc.2024.04.009
|
| 6 |
McKenzie L. Schaefer, Patrick L. Quinn, Alexander H. Shannon, Laith Abushahin, Jordan M. Cloyd, Mary E. Dillhoff, Ning Jin, Ashish Manne, Arjun Mittra, Anne M. Noonan, Timothy M. Pawlik, Shafia Rahman, Aslam Ejaz. Simultaneous resection of pancreatic cancer and liver metastases following total neoadjuvant therapy: A case series and analysis of the National Cancer Database. Annals of Hepato-Biliary-Pancreatic Surgery 2026; 30(1): 58 doi: 10.14701/ahbps.25-209
|
| 7 |
Young Seok Cho, Hanhee Cho, Ha Rin Kim, Seong Jin Park, Joo Hye Yeo, Yoon Gun Ko, Jinu Lee, Sang Yoon Kim, Kwangmeyung Kim, Youngro Byun. Macropinocytosis-targeted peptide-docetaxel conjugate for bystander pancreatic cancer treatment. Journal of Controlled Release 2024; 376: 829 doi: 10.1016/j.jconrel.2024.10.070
|
| 8 |
Felice Giuliante, Elena Panettieri, Andrea Campisi, Alessandro Coppola, Maria Vellone, Agostino M. De Rose, Francesco Ardito. Treatment of oligo-metastatic pancreatic ductal adenocarcinoma to the liver: is there a role for surgery? A narrative review. International Journal of Surgery 2024; 110(10): 6163 doi: 10.1097/JS9.0000000000001665
|
| 9 |
Jacob M. Ranot, Jemila S. Hamid, Azita Montazeri, Kelly Harper, Christopher McCudden, Terence N. Moyana. Well-Differentiated Jejunoileal Neuroendocrine Tumors and Corresponding Liver Metastases: Mesenteric Fibrogenesis and Extramural Vascular Invasion in Tumor Progression. Cancers 2025; 17(9): 1486 doi: 10.3390/cancers17091486
|
| 10 |
Matheus Hermes Leal, Rafaella Funk, Laura Lima Camargo, Francisca Rego, Rui Nunes. EHR-Based Advanced Care Planning and Late-Stage Cancer Treatment in a Middle-Income Country: A Retrospective Cohort Study. Healthcare 2026; 14(2): 139 doi: 10.3390/healthcare14020139
|
| 11 |
Dorsa Safari, Mohammad Fakhrolmobasheri, Saeed Soleymanjahi. Efficacy and safety of intraperitoneal chemotherapy for pancreatic cancer. BMC Surgery 2024; 24(1) doi: 10.1186/s12893-024-02526-9
|
